blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0660714

EP0660714 - NOVEL LIPOSOMAL DRUG DELIVERY SYSTEMS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  07.05.2004
Database last updated on 03.10.2024
Most recent event   Tooltip22.04.2005Lapse of the patent in a contracting state
New state(s): LU
published on 08.06.2005  [2005/23]
Applicant(s)For all designated states
IMARX PHARMACEUTICAL CORP.
1635 East 18th Street
Tucson, AZ 85719 / US
[N/P]
Former [1997/21]For all designated states
ImaRx Pharmaceutical Corp.
1635 East 18th Street
Tucson, AZ 85719 / US
Former [1995/27]For all designated states
UNGER, Evan C
13365 E. Camino La Cebadilla
Tucson, AZ 85749 / US
For all designated states
WU, Guanli
2602 W. Aiden Street
Tucson, AZ 85745 / US
Inventor(s)01 / Unger, Evan C.
13365 E. Camino La Cebadilla
Tucson, Arizona 85749 / US
02 / Wu, Guanli
2602 W. Aiden Street
Tucson, Arizona 85745 / US
[1997/21]
Former [1995/27]01 / see applicant
...
Representative(s)Hallybone, Huw George, et al
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[N/P]
Former [1995/27]Hallybone, Huw George, et al
CARPMAELS AND RANSFORD 43 Bloomsbury Square
London WC1A 2RA / GB
Application number, filing date92912662.131.03.1992
[1995/27]
WO1992US02614
Priority number, dateUS1991071689918.06.1991         Original published format: US 716899
[1995/27]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9222298
Date:23.12.1992
Language:EN
[1992/32]
Type: A1 Application with search report 
No.:EP0660714
Date:05.07.1995
Language:EN
The application published by WIPO in one of the EPO official languages on 23.12.1992 takes the place of the publication of the European patent application.
[1995/27]
Type: B1 Patent specification 
No.:EP0660714
Date:02.07.2003
Language:EN
[2003/27]
Search report(s)International search report - published on:US23.12.1992
(Supplementary) European search report - dispatched on:EP14.05.1996
ClassificationIPC:A61K9/127
[1996/24]
CPC:
A61K9/1278 (EP); A61K41/0028 (EP); A61K41/0052 (EP);
A61K47/6911 (EP); A61K47/6925 (EP); A61K49/1815 (EP);
A61K49/223 (EP); A61K49/227 (EP); A61K9/127 (EP);
A61K9/1277 (EP) (-)
Former IPC [1995/27]A61K31/47
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   MC,   NL,   SE [1995/27]
TitleGerman:NEUE LIPOSOMALE ARZNEIMITTELFREISETZUNGSSYSTEME[2002/39]
English:NOVEL LIPOSOMAL DRUG DELIVERY SYSTEMS[1995/27]
French:NOUVEAUX SYSTEMES D'APPORT DE MEDICAMENTS AUX LIPOSOMES[1995/27]
Former [1995/27]NEUE LIPOSOMALE ARZNEIMITTELFREINETZUNGSSYSTEME
Entry into regional phase18.01.1994National basic fee paid 
18.01.1994Search fee paid 
18.01.1994Designation fee(s) paid 
18.01.1994Examination fee paid 
Examination procedure07.01.1993Request for preliminary examination filed
International Preliminary Examining Authority: DE
18.01.1994Examination requested  [1995/27]
31.10.1996Despatch of a communication from the examining division (Time limit: M04)
26.02.1997Reply to a communication from the examining division
24.11.1997Despatch of a communication from the examining division (Time limit: M04)
25.03.1998Reply to a communication from the examining division
15.01.1999Despatch of a communication from the examining division (Time limit: M04)
24.05.1999Reply to a communication from the examining division
19.10.1999Despatch of a communication from the examining division (Time limit: M06)
28.04.2000Reply to a communication from the examining division
29.11.2000Despatch of a communication from the examining division (Time limit: M04)
03.04.2001Reply to a communication from the examining division
19.10.2001Despatch of a communication from the examining division (Time limit: M04)
25.02.2002Reply to a communication from the examining division
08.10.2002Communication of intention to grant the patent
09.04.2003Fee for grant paid
09.04.2003Fee for publishing/printing paid
Opposition(s)05.04.2004No opposition filed within time limit [2004/26]
Fees paidRenewal fee
18.01.1994Renewal fee patent year 03
09.03.1995Renewal fee patent year 04
08.03.1996Renewal fee patent year 05
01.04.1997Renewal fee patent year 06
10.03.1998Renewal fee patent year 07
11.03.1999Renewal fee patent year 08
13.03.2000Renewal fee patent year 09
16.03.2001Renewal fee patent year 10
13.03.2002Renewal fee patent year 11
11.03.2003Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT02.07.2003
BE02.07.2003
DK02.10.2003
GR02.10.2003
SE02.10.2003
ES13.10.2003
LU31.03.2004
MC31.03.2004
[2005/23]
Former [2005/02]AT02.07.2003
BE02.07.2003
DK02.10.2003
GR02.10.2003
SE02.10.2003
ES13.10.2003
MC31.03.2004
Former [2004/46]AT02.07.2003
BE02.07.2003
DK02.10.2003
GR02.10.2003
SE02.10.2003
ES13.10.2003
Former [2004/29]AT02.07.2003
BE02.07.2003
DK02.10.2003
GR02.10.2003
SE02.10.2003
Former [2004/28]AT02.07.2003
BE02.07.2003
GR02.10.2003
SE02.10.2003
Former [2004/16]AT02.07.2003
GR02.10.2003
SE02.10.2003
Former [2004/14]AT02.07.2003
GR02.10.2003
Documents cited:Search[A]EP0243947  (DORNIER MEDIZINTECHNIK [DE]) [A] 1-10* the whole document *
International search[A]US4657756  (RASOR JULIA S [US], et al);
 [XY]US4675310  (CHAPMAN DENNIS [GB], et al);
 [XY]US4900540  (RYAN PATRICK J [US], et al)
ExaminationDE2818655
 WO8603938
 WO9000389
 DE4013580
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.